Li Xiao C, Gu Victor, Miguel-Qin Elise, Zhuo Jia L
Laboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology, Division of Nephrology, Department of Medicine, and Cardiovascular Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi.
Laboratory of Receptor and Signal Transduction, Department of Pharmacology and Toxicology, Division of Nephrology, Department of Medicine, and Cardiovascular Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi
Am J Physiol Renal Physiol. 2014 Oct 15;307(8):F949-61. doi: 10.1152/ajprenal.00199.2014. Epub 2014 Aug 27.
Caveolin 1 (CAV-1) functions not only as a constitutive scaffolding protein of caveolae but also as a vesicular transporter and signaling regulator. In the present study, we tested the hypothesis that CAV-1 knockout (CAV-1 KO) inhibits ANG II type 1 [AT1 (AT1a)] receptor-mediated uptake of ANG II in the proximal tubule and attenuates blood pressure responses in ANG II-induced hypertension. To determine the role of CAV-1 in mediating the uptake of FITC-labeled ANG II, wild-type (WT) mouse proximal convoluted tubule cells were transfected with CAV-1 small interfering (si)RNA for 48 h before AT1 receptor-mediated uptake of FITC-labeled ANG II was studied. CAV-1 siRNA knocked down CAV-1 expression by >90% (P < 0.01) and inhibited FITC-labeled ANG II uptake by >50% (P < 0.01). Moreover, CAV-1 siRNA attenuated ANG II-induced activation of MAPK ERK1/2 and Na(+)/H(+) exchanger 3 expression, respectively (P < 0.01). To determine whether CAV-1 regulates ANG II uptake in the proximal tubule, Alexa 488-labeled ANG II was infused into anesthetized WT and CAV-1 KO mice for 60 min (20 ng/min iv). Imaging analysis revealed that Alexa 488-labeled ANG II uptake was decreased by >50% in CAV-1 KO mice (P < 0.01). Furthermore, Val(5)-ANG II was infused into WT and CAV-1 KO mice for 2 wk (1.5 mg·kg(-1)·day(-1) ip). Basal systolic pressure was higher, whereas blood pressure and renal excretory and signaling responses to ANG II were attenuated, in CAV-1 KO mice (P < 0.01). We concluded that CAV-1 plays an important role in AT1 receptor-mediated uptake of ANG II in the proximal tubule and modulates blood pressure and renal responses to ANG II.
小窝蛋白1(CAV-1)不仅作为小窝的组成性支架蛋白发挥作用,还作为囊泡转运体和信号调节剂发挥作用。在本研究中,我们检验了以下假设:CAV-1基因敲除(CAV-1 KO)会抑制近端小管中血管紧张素II 1型[AT1(AT1a)]受体介导的血管紧张素II摄取,并减弱血管紧张素II诱导的高血压中的血压反应。为了确定CAV-1在介导异硫氰酸荧光素标记的血管紧张素II摄取中的作用,在研究AT1受体介导的异硫氰酸荧光素标记的血管紧张素II摄取之前,将野生型(WT)小鼠近端曲管细胞用CAV-1小干扰(si)RNA转染48小时。CAV-1 siRNA使CAV-1表达降低>90%(P<0.01),并使异硫氰酸荧光素标记的血管紧张素II摄取减少>50%(P<0.01)。此外,CAV-1 siRNA分别减弱了血管紧张素II诱导的MAPK ERK1/2激活和钠/氢交换体3表达(P<0.01)。为了确定CAV-1是否调节近端小管中的血管紧张素II摄取,将Alexa 488标记的血管紧张素II注入麻醉的WT和CAV-1 KO小鼠体内60分钟(静脉注射20 ng/分钟)。成像分析显示,CAV-1 KO小鼠中Alexa 488标记的血管紧张素II摄取减少>50%(P<0.01)。此外,将缬氨酸5-血管紧张素II注入WT和CAV-1 KO小鼠体内2周(腹腔注射1.5 mg·kg-1·天-1)。CAV-1 KO小鼠的基础收缩压较高,而对血管紧张素II的血压、肾脏排泄和信号反应减弱(P<0.01)。我们得出结论,CAV-1在近端小管中AT1受体介导的血管紧张素II摄取中起重要作用,并调节血压和肾脏对血管紧张素II的反应。